Does NEBIVOLOL Cause Agranulocytosis? 24 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Agranulocytosis have been filed in association with NEBIVOLOL (nebivolol). This represents 0.4% of all adverse event reports for NEBIVOLOL.
24
Reports of Agranulocytosis with NEBIVOLOL
0.4%
of all NEBIVOLOL reports
2
Deaths
23
Hospitalizations
How Dangerous Is Agranulocytosis From NEBIVOLOL?
Of the 24 reports, 2 (8.3%) resulted in death, 23 (95.8%) required hospitalization, and 1 (4.2%) were considered life-threatening.
Is Agranulocytosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NEBIVOLOL. However, 24 reports have been filed with the FAERS database.
What Other Side Effects Does NEBIVOLOL Cause?
Hypotension (487)
Drug ineffective (430)
Bradycardia (371)
Dyspnoea (364)
Fall (320)
Acute kidney injury (300)
Dizziness (294)
Off label use (277)
Fatigue (257)
Hypertension (249)
What Other Drugs Cause Agranulocytosis?
CLOZAPINE (1,766)
CYCLOPHOSPHAMIDE (1,242)
RITUXIMAB (1,154)
SULFAMETHOXAZOLE\TRIMETHOPRIM (797)
PANTOPRAZOLE (599)
METHOTREXATE (550)
SODIUM (549)
EPIRUBICIN (491)
METAMIZOLE (438)
DOCETAXEL (436)
Which NEBIVOLOL Alternatives Have Lower Agranulocytosis Risk?
NEBIVOLOL vs NECITUMUMAB
NEBIVOLOL vs NEDAPLATIN
NEBIVOLOL vs NEFAZODONE
NEBIVOLOL vs NEFOPAM
NEBIVOLOL vs NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE\NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIG